It is termed a targeted therapy since it precisely targets the CD38  which happen to be overexpressed about the multiple myeloma cells. Daratumumab is from a class of medicines termed CD38 monoclonal antibodies. Review the full affected person medication information and examine this information and any inquiries you might have with your doctor or